PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a certificate dated July 15, 2019, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2019. This is for your kind information and record please. PANACEA BIOTEC LTD. - 531349 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vinod GoelDesignation :- Company Secretary and Compliance Officer PANACEA BIOTEC LTD. - 531349 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Panacea Biotec Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here PANACEA BIOTEC LTD. - 531349 - Shareholder Meeting - Scrutinizer''s Report
This is in continuation of our earlier letter dated July 06, 2019 informing that the detailed results of remote e-voting and the poll conducted at the Extraordinary General Meeting ('EGM') of the Company held on July 06, 2019, as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations') shall be forwarded to you on the receipt of Scrutinizer's Report. We would like to inform you that all the resolutions mentioned in the EGM notice have been passed by shareholders with requisite majority. Pursuant to Regulation 44(3) of the SEBI LODR Regulations read with amended Rule 20 of Companies (Management and Administration) Rules, 2015, the combined results of remote e-voting and poll conducted at the EGM along with the Scrutinizer's Report is enclosed herewith. PANACEA BIOTEC LTD. - 531349 - Details Of The Voting Results Pursuant To Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is in continuation of our earlier letter dated July 06, 2019 informing that the detailed results of remote e-voting and the poll conducted at the Extraordinary General Meeting ('EGM') of the Company held on July 06, 2019, as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations') shall be forwarded to you on the receipt of Scrutinizer's Report. We would like to inform you that all the resolutions mentioned in the EGM notice have been passed by shareholders with requisite majority. Pursuant to Regulation 44(3) of the SEBI LODR Regulations read with amended Rule 20 of Companies (Management and Administration) Rules, 2015, the combined results of remote e-voting and poll conducted at the EGM along with the Scrutinizer's Report is enclosed herewith. PANACEA BIOTEC LTD. - 531349 - Proceedings Of Extraordinary General Meeting Held On July 06, 2019
Pursuant to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), please find enclosed herewith the proceedings of the Extraordinary General Meeting of the Company held on July 06, 2019, at the registered office of the Company at Ambala-Chandigarh Highway, Lalru - 140501, Punjab. PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith details of Shares dematerialized during the month of June, 2019 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions in the format specified in the relevant accounting standards for half year ended March 31,2019. Panacea Biotec Ltd - 531349 - Closure of Trading Window
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company and Material Subsidiaries of the Company from July 01, 2019 till completion of 48 hours from the announcement to the Stock Exchanges of the Unaudited financial results of the Company for the quarter ending June 30, 2019. The date of meeting of the Board of Directors to approve the Unaudited financial results of the Company for the quarter ending June 30, 2019 will be informed in due course. Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated June 12, 2019 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the newspaper advertisements regarding Notice of EGM and Remote E-voting Information published on June 14, 2019 in the following newspapers:- Business Standard, English Edition Desh Sewak, Punjabi Edition